The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

被引:189
作者
Arnon, TI
Achdout, H
Lieberman, N
Gazit, R
Gonen-Gross, T
Katz, G
Bar-Ilan, A
Bloushtain, N
Lev, M
Joseph, A
Kedar, E
Porgador, A
Mandelboim, O [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel
关键词
D O I
10.1182/blood-2003-05-1716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The destruction of viral-infected and tumor cells is mediated in part via the lysis receptor of natural killer (NK) cells, NKp46. The nature, however, of its lysis ligands expressed on target cells is poorly defined. Recently, we have identified a novel functional interaction between the lysis receptors NKp46 and NKp44 and the hemagglutinin of influenza and hemgglutinin-neuroaminidase of Sendai viruses. This recognition depends on the sialylation of NKp46 and NKp44 receptors. In this study, we expand the significance of these observations by demonstrating a conserved pattern of NKp46 and NKp44 recognition by various hemagglutinins derived from different viral strains. We further establish that this recognition is direct and mainly mediated via alpha2,6-linked sialic acid carried by NKp46. In addition, we demonstrate that the ability of NKp46 to recognize target cells is confined to the membrane proximal domain, and largely relies on the highly conserved sugar-carrying residue, Thr 225. This residue plays a critical dual role in NKp46 interactions with both viral hemagglutinins and the unknown tumor ligands via different mechanisms. These results may explain the ability of NK cells to kill such a broad spectrum of viral-infected and tumor cells.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 46 条
  • [1] Enhanced recognition of human NK receptors after influenza virus infection
    Achdout, H
    Arnon, TI
    Markel, G
    Gonen-Gross, T
    Lieberman, N
    Gazit, R
    Joseph, A
    Kedar, E
    Mandelboim, O
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 915 - 923
  • [2] Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO
  • [3] 2-A
  • [4] Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults
    Ben-Yehuda, A
    Joseph, A
    Zeira, E
    Even-Chen, S
    Louria-Hayon, I
    Babai, I
    Zakay-Rones, Z
    Greenbaum, E
    Barenholz, Y
    Kedar, E
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (04) : 560 - 567
  • [5] Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO
  • [6] 2-O
  • [7] Human natural killer cell receptors and co-receptors
    Biassoni, R
    Cantoni, C
    Pende, D
    Sivori, S
    Parolini, S
    Vitale, M
    Bottino, C
    Moretta, A
    [J]. IMMUNOLOGICAL REVIEWS, 2001, 181 : 203 - 214
  • [8] Natural killer cells in antiviral defense: Function and regulation by innate cytokines
    Biron, CA
    Nguyen, KB
    Pien, GC
    Cousens, LP
    Salazar-Mather, TP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 189 - 220
  • [9] NK cells and NKT cells in innate defense against viral infections
    Biron, CA
    Brossay, L
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) : 458 - 464
  • [10] NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
    Cantoni, C
    Bottino, C
    Vitale, M
    Pessino, A
    Augugliaro, R
    Malaspina, A
    Parolini, S
    Moretta, L
    Moretta, A
    Biassoni, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 787 - 795